Pharmarise Holdings Corporation (TYO:2796)
Japan flag Japan · Delayed Price · Currency is JPY
489.00
-2.00 (-0.41%)
Jul 31, 2026, 3:30 PM JST

Pharmarise Holdings Financials Overview

Millions JPY. Fiscal year is Jun - May.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Revenue
69,51269,51263,50854,46652,03051,608
Revenue Growth
9.45%9.45%16.60%4.68%0.82%-1.37%
Gross Profit
9,4599,4598,9668,4498,1348,117
Operating Income
9479472959161,4391,521
Net Income
114114-367-351333447
Earnings Per Share
9.629.62-32.42-33.3526.8636.22
EPS Growth
-----25.83%4.70%

Revenue by Segment

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Storage and Management of Medical Documents
647647609664646699
Dispensing Pharmacy
59,33159,33152,62544,17842,32742,038
Medical Mall Management
505505511506505503
Others
9869861,064834779764
Drug/Convenience Store
8,0428,0428,6968,2837,7717,602
Total
69,51169,51163,50554,46552,02851,606

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Cash & Investments
6,0126,0124,9117,1504,7423,991
Total Debt
15,15215,15214,27912,7499,1389,912
Net Cash (Debt)
-9,140-9,140-9,368-5,599-4,396-5,921
Net Cash Growth
------
Net Cash Per Share
-766.78-766.78-827.45-532.02-352.52-477.64

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Operating Cash Flow
3,2783,2781,3112,7142,520713
Capital Expenditures
-696-696-637-472-380-379
Free Cash Flow
2,5822,5826742,2422,140334
Free Cash Flow Growth
283.09%283.09%-69.94%4.77%540.72%-76.76%

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMay '26 May '26 May '25 May '24 May '23 May '22
Gross Margin
13.61%13.61%14.12%15.51%15.63%15.73%
Operating Margin
1.36%1.36%0.46%1.68%2.77%2.95%
Pretax Margin
1.00%1.00%0.02%0.26%2.02%2.56%
Profit Margin
0.16%0.16%-0.58%-0.64%0.64%0.87%
FCF Margin
3.71%3.71%1.06%4.12%4.11%0.65%

Dividends

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
Dividend Per Share
14.00014.00014.00014.00014.00014.000
Dividend Per Share Growth
0%0%0%0%0%0%
Dividend Yield
2.86%2.77%2.96%2.29%2.50%2.15%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 May '26 May '25 May '24 May '23 May '22
PE Ratio
50.8351.06--17.2915.23
Forward PE
-7.307.307.307.307.30
P/FCF Ratio
2.182.258.183.242.6920.39
PS Ratio
0.080.080.090.130.110.13